Views & Analysis A novel approach to detecting Alzheimer’s early The grey matter in the brain may hold vital clues for early, accurate detection in Alzheimer’s, and potentially also help pharma to find new drug treatments.
News GSK boosts anti-infectives pipeline with Scynexis antifungal Last year, GSK said it was planning to invest a cool £1 billion in infectious d
R&D Sponsored Trials and tribulations of drug development What does it take to establish new treatments for rare diseases?